Sunrise, a sleep therapy provider, has raised USD 6 million in a funding round which saw participation from the Alexa Fund and French medical investor UI-Investissement (Majycc Innovation Santé). This brings the total funds raised by the company to EUR 29.9 million (USD 32.4 million).
The raised funding is set to be used to grow the company's geographical reach.
As of November 2023, Sunrise has received two FDA approvals in the US and retains renewed CE certification under the European Medical Device Regulation.
By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.